Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering

Cancer Treat Res. 1993:62:309-22. doi: 10.1007/978-1-4615-3518-8_37.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / blood
  • Bleomycin / administration & dosage
  • Bone Neoplasms / blood
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / mortality
  • Bone Neoplasms / pathology
  • Bone Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Child
  • Child, Preschool
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Dactinomycin / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Male
  • Methotrexate / administration & dosage
  • New York / epidemiology
  • Osteosarcoma / blood
  • Osteosarcoma / drug therapy*
  • Osteosarcoma / mortality
  • Osteosarcoma / pathology
  • Osteosarcoma / surgery
  • Prognosis
  • Proportional Hazards Models
  • Racial Groups
  • Retrospective Studies
  • Risk
  • Survival Rate
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Bleomycin
  • Dactinomycin
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Methotrexate